1.
Kulumbegov B, Gotua M, Chikovani T. Type I and Type IIb Autoimmunity in Chronic Spontaneous Urticaria Patients: Evaluating the Clinical Response to Omalizumab. GS [Internet]. 2023 May 8 [cited 2024 Sep. 19];5(2):109-16. Available from: https://journals.4science.ge/index.php/GS/article/view/1727